{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:52:28Z","timestamp":1787064748816,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005423","name":"Akademiska Sjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004973","name":"Childhood Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008550","name":"Swedish Diabetes Association Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-02312"],"award-info":[{"award-number":["2020-02312"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2024-03659"],"award-info":[{"award-number":["2024-03659"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ebiom.2025.106033","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:35:24Z","timestamp":1763768124000},"page":"106033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Positron emission tomography to assess drug occupancy at peripheral and central incretin receptors"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8567-2277","authenticated-orcid":false,"given":"Amina","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Velikyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-3884","authenticated-orcid":false,"given":"Mengfei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.106033_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/DMSO.S7004","article-title":"Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes \u2013 a review","volume":"3","author":"Hansen","year":"2010","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106033_bib2","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00125-023-05929-0","article-title":"Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy","volume":"66","author":"Tsch\u00f6p","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.ebiom.2025.106033_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.106033_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.106033_bib5","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1172\/JCI78371","article-title":"Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight","volume":"124","author":"Baggio","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.106033_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13300-011-0002-3","article-title":"Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus","volume":"2","author":"Koliaki","year":"2011","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ebiom.2025.106033_bib7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1476-5381.2009.00376.x","article-title":"Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?","volume":"157","author":"Grieve","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2025.106033_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNH.0000000000000894","article-title":"Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease","volume":"32","author":"Alicic","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ebiom.2025.106033_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2025.106033_bib10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s42255-025-01294-x","article-title":"GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice","volume":"7","author":"Gutgesell","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.ebiom.2025.106033_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134315","article-title":"Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review","volume":"27","author":"Chavda","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106033_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106033_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2021.12.005","article-title":"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1\/GIP\/GCG receptor triagonist","volume":"34","author":"Bossart","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2025.106033_bib14","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/jdi.13896","article-title":"Potential of a glucagon-like peptide-1 receptor\/glucose-dependent insulinotropic polypeptide receptor\/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes","volume":"13","author":"Araki","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106033_bib15","article-title":"Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106033_bib16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/db20-1096","article-title":"Drug occupancy assessment at the glucose-dependent insulinotropic polypeptide receptor by positron emission tomography","volume":"70","author":"Eriksson","year":"2021","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106033_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73815-5","article-title":"Receptor occupancy of dual glucagon-like peptide 1\/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes","volume":"10","author":"Eriksson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.106033_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/cpt.2548","article-title":"PET as a translational tool in drug development for neuroscience compounds","volume":"111","author":"Varrone","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106033_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11307-013-0700-5","article-title":"64Cu- and 68Ga-labelled [Nle14,Lys 40(Ahx-NODAGA)NH2]-Exendin-4 for pancreatic beta cell imaging in rats","volume":"16","author":"Mikkola","year":"2014","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106033_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-024-01159-6","article-title":"Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas","volume":"14","author":"Jansen","year":"2024","journal-title":"EJNMMI Res"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106033_bib21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nucmedbio.2014.03.017","article-title":"Pre-clinical evaluation of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for imaging of insulinoma","volume":"41","author":"Selvaraju","year":"2014","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106033_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/ph16010061","article-title":"Imaging of the glucose-dependent insulinotropic polypeptide receptor using a novel radiolabeled peptide rationally designed based on endogenous GIP and synthetic Exendin-4 sequences","volume":"16","author":"Velikyan","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106033_bib23","first-page":"794","article-title":"Glucagonlike peptide-1 receptor imaging in individuals with type 2 diabetes","volume":"63","author":"Eriksson","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ebiom.2025.106033_bib24","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting","first-page":"256","author":"Motulsky","year":"2004"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106033_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.120.000371","article-title":"Understanding exposure-receptor occupancy relationships for metabotropic glutamate receptor 5 negative allosteric modulators across a range of preclinical and clinical studies","volume":"377","author":"Bennett","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2025.106033_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.ebiom.2025.106033_bib27","author":"Lilly"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106033_bib28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"Korner","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ebiom.2025.106033_bib29","article-title":"Hormonal regulators of appetite","volume":"2009","author":"Austin","year":"2008","journal-title":"Int J Pediatr Endocrinol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106033_bib30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2967\/jnumed.112.114066","article-title":"In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4","volume":"54","author":"Selvaraju","year":"2013","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106033_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2017-00235","article-title":"The versatile tanycyte: a hypothalamic integrator of reproduction and energy metabolism","volume":"39","author":"Prevot","year":"2018","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106033_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","article-title":"Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions","volume":"34","author":"Imbernon","year":"2022","journal-title":"Cell Metab"},{"issue":"14","key":"10.1016\/j.ebiom.2025.106033_bib33","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.ebiom.2025.106033_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molmet.2018.11.005","article-title":"GLP-1 modulates the supramammillary nucleus-lateral hypothalamic neurocircuit to control ingestive and motivated behavior in a sex divergent manner","volume":"20","author":"L\u00f3pez-Ferreras","year":"2019","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106033_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061965","article-title":"Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.106033_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/bph.15682","article-title":"Glucagon-like peptide-1 (GLP-1) signalling in the brain: from neural circuits and metabolism to therapeutics","volume":"179","author":"Kabahizi","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106033_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00441-012-1421-9","article-title":"Different vascular permeability between the sensory and secretory circumventricular organs of adult mouse brain","volume":"349","author":"Morita","year":"2012","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ebiom.2025.106033_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103739","article-title":"Reagents and models for detecting endogenous GLP1R and GIPR","volume":"74","author":"Ast","year":"2021","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106033_bib39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist\u2013induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106033_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2017.06.031","article-title":"Central administration of GLP-1 and GIP decreases feeding in mice","volume":"490","author":"NamKoong","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106033_bib41","first-page":"111","article-title":"Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use","volume":"7","author":"Velikyan","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425004773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425004773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:13:12Z","timestamp":1773817992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425004773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"alternative-id":["S2352396425004773"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106033","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positron emission tomography to assess drug occupancy at peripheral and central incretin receptors","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106033"}}